沃华医药
(002107)
| 流通市值：36.17亿 | | | 总市值：36.54亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 393,349,512.77 | 219,045,381.55 | 816,952,424.84 | 624,613,354.3 |
| 营业总成本 | 315,038,296 | 177,276,991.23 | 721,298,250.06 | 562,597,697.56 |
| 其他经营收益 | | | | |
| 营业利润 | 80,710,060.22 | 43,522,680.43 | 103,598,043.94 | 68,533,062.66 |
| 利润总额 | 81,101,316.15 | 43,891,565.18 | 102,379,572.89 | 68,484,499.35 |
| 净利润 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 | 58,970,616.32 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 | 58,970,616.32 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 559,798,896.26 | 539,479,237.17 | 566,770,936.67 | 555,262,731.35 |
| 非流动资产: | | | | |
| 非流动资产合计 | 395,798,845.23 | 403,160,722.74 | 410,599,030.53 | 418,431,414.17 |
| 资产总计 | 955,597,741.49 | 942,639,959.91 | 977,369,967.2 | 973,694,145.52 |
| 流动负债: | | | | |
| 流动负债合计 | 237,076,365.13 | 256,280,232.63 | 240,731,078.72 | 247,672,121.67 |
| 非流动负债: | | | | |
| 非流动负债合计 | 14,388,764.99 | 14,809,356.46 | 15,738,794.43 | 17,302,385.1 |
| 负债合计 | 251,465,130.12 | 271,089,589.09 | 256,469,873.15 | 264,974,506.77 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 707,112,139.6 | 676,194,581.49 | 723,818,446.05 | 692,098,145.75 |
| 股东权益合计 | 704,132,611.37 | 671,550,370.82 | 720,900,094.05 | 708,719,638.75 |
| 负债和股东权益合计 | 955,597,741.49 | 942,639,959.91 | 977,369,967.2 | 973,694,145.52 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 454,230,641.4 | 256,981,306.76 | 920,068,558.07 | 698,558,451.83 |
| 经营活动现金流出小计 | 372,863,138.92 | 189,337,935.55 | 791,542,942.07 | 589,857,198.99 |
| 经营活动产生的现金流量净额 | 81,367,502.48 | 67,643,371.21 | 128,525,616 | 108,701,252.84 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | - | 15,473,572 | 15,470,272 |
| 投资活动现金流出小计 | 1,095,065.21 | 717,575.21 | 864,503.16 | 546,677.53 |
| 投资活动产生的现金流量净额 | -1,095,065.21 | -717,575.21 | 14,609,068.84 | 14,923,594.47 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 88,184,286.48 | 87,901,689.93 | 91,973,084.68 | 73,987,831.4 |
| 筹资活动产生的现金流量净额 | -88,184,286.48 | -87,901,689.93 | -91,973,084.68 | -73,987,831.4 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -7,911,849.21 | -20,975,893.93 | 51,161,600.16 | 49,637,015.91 |
| 期末现金及现金等价物余额 | 386,125,956.85 | 373,061,912.13 | 394,037,806.06 | 392,513,221.81 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -7,911,849.21 | - | 51,161,600.16 | - |